Copyright Reports & Markets. All rights reserved.

Global Crizotinib API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Crizotinib API Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Purity≥99%
    • 1.3.3 Purity<99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Crizotinib API Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Online Sales
    • 1.4.3 Offline Sales
  • 1.5 Global Crizotinib API Market Size & Forecast
    • 1.5.1 Global Crizotinib API Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Crizotinib API Sales Quantity (2021-2032)
    • 1.5.3 Global Crizotinib API Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 MSN Laboratories
    • 2.1.1 MSN Laboratories Details
    • 2.1.2 MSN Laboratories Major Business
    • 2.1.3 MSN Laboratories Crizotinib API Product and Services
    • 2.1.4 MSN Laboratories Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 MSN Laboratories Recent Developments/Updates
  • 2.2 Greencross
    • 2.2.1 Greencross Details
    • 2.2.2 Greencross Major Business
    • 2.2.3 Greencross Crizotinib API Product and Services
    • 2.2.4 Greencross Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Greencross Recent Developments/Updates
  • 2.3 Hetero Labs
    • 2.3.1 Hetero Labs Details
    • 2.3.2 Hetero Labs Major Business
    • 2.3.3 Hetero Labs Crizotinib API Product and Services
    • 2.3.4 Hetero Labs Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Hetero Labs Recent Developments/Updates
  • 2.4 Vama Lifecare
    • 2.4.1 Vama Lifecare Details
    • 2.4.2 Vama Lifecare Major Business
    • 2.4.3 Vama Lifecare Crizotinib API Product and Services
    • 2.4.4 Vama Lifecare Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Vama Lifecare Recent Developments/Updates
  • 2.5 Croissance Biomed
    • 2.5.1 Croissance Biomed Details
    • 2.5.2 Croissance Biomed Major Business
    • 2.5.3 Croissance Biomed Crizotinib API Product and Services
    • 2.5.4 Croissance Biomed Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Croissance Biomed Recent Developments/Updates
  • 2.6 Medicine House
    • 2.6.1 Medicine House Details
    • 2.6.2 Medicine House Major Business
    • 2.6.3 Medicine House Crizotinib API Product and Services
    • 2.6.4 Medicine House Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Medicine House Recent Developments/Updates
  • 2.7 Apothecon Pharmaceuticals
    • 2.7.1 Apothecon Pharmaceuticals Details
    • 2.7.2 Apothecon Pharmaceuticals Major Business
    • 2.7.3 Apothecon Pharmaceuticals Crizotinib API Product and Services
    • 2.7.4 Apothecon Pharmaceuticals Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Apothecon Pharmaceuticals Recent Developments/Updates
  • 2.8 Tocris Bioscience
    • 2.8.1 Tocris Bioscience Details
    • 2.8.2 Tocris Bioscience Major Business
    • 2.8.3 Tocris Bioscience Crizotinib API Product and Services
    • 2.8.4 Tocris Bioscience Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Tocris Bioscience Recent Developments/Updates
  • 2.9 Selleck Chemicals
    • 2.9.1 Selleck Chemicals Details
    • 2.9.2 Selleck Chemicals Major Business
    • 2.9.3 Selleck Chemicals Crizotinib API Product and Services
    • 2.9.4 Selleck Chemicals Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Selleck Chemicals Recent Developments/Updates
  • 2.10 Cayman Chemical
    • 2.10.1 Cayman Chemical Details
    • 2.10.2 Cayman Chemical Major Business
    • 2.10.3 Cayman Chemical Crizotinib API Product and Services
    • 2.10.4 Cayman Chemical Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Cayman Chemical Recent Developments/Updates
  • 2.11 Anant Pharmaceuticals
    • 2.11.1 Anant Pharmaceuticals Details
    • 2.11.2 Anant Pharmaceuticals Major Business
    • 2.11.3 Anant Pharmaceuticals Crizotinib API Product and Services
    • 2.11.4 Anant Pharmaceuticals Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Anant Pharmaceuticals Recent Developments/Updates
  • 2.12 Adooq Bioscience
    • 2.12.1 Adooq Bioscience Details
    • 2.12.2 Adooq Bioscience Major Business
    • 2.12.3 Adooq Bioscience Crizotinib API Product and Services
    • 2.12.4 Adooq Bioscience Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Adooq Bioscience Recent Developments/Updates
  • 2.13 Focus Biomolecules
    • 2.13.1 Focus Biomolecules Details
    • 2.13.2 Focus Biomolecules Major Business
    • 2.13.3 Focus Biomolecules Crizotinib API Product and Services
    • 2.13.4 Focus Biomolecules Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Focus Biomolecules Recent Developments/Updates
  • 2.14 LC Laboratories
    • 2.14.1 LC Laboratories Details
    • 2.14.2 LC Laboratories Major Business
    • 2.14.3 LC Laboratories Crizotinib API Product and Services
    • 2.14.4 LC Laboratories Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 LC Laboratories Recent Developments/Updates
  • 2.15 Hefei Home Sunshine Pharmaceutical Technology
    • 2.15.1 Hefei Home Sunshine Pharmaceutical Technology Details
    • 2.15.2 Hefei Home Sunshine Pharmaceutical Technology Major Business
    • 2.15.3 Hefei Home Sunshine Pharmaceutical Technology Crizotinib API Product and Services
    • 2.15.4 Hefei Home Sunshine Pharmaceutical Technology Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Hefei Home Sunshine Pharmaceutical Technology Recent Developments/Updates
  • 2.16 Chongqing Huapont Shengchem Pharm
    • 2.16.1 Chongqing Huapont Shengchem Pharm Details
    • 2.16.2 Chongqing Huapont Shengchem Pharm Major Business
    • 2.16.3 Chongqing Huapont Shengchem Pharm Crizotinib API Product and Services
    • 2.16.4 Chongqing Huapont Shengchem Pharm Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Chongqing Huapont Shengchem Pharm Recent Developments/Updates
  • 2.17 Xuzhou Wanbang Jinqiao Pharmaceutical
    • 2.17.1 Xuzhou Wanbang Jinqiao Pharmaceutical Details
    • 2.17.2 Xuzhou Wanbang Jinqiao Pharmaceutical Major Business
    • 2.17.3 Xuzhou Wanbang Jinqiao Pharmaceutical Crizotinib API Product and Services
    • 2.17.4 Xuzhou Wanbang Jinqiao Pharmaceutical Crizotinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Xuzhou Wanbang Jinqiao Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Crizotinib API by Manufacturer

  • 3.1 Global Crizotinib API Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Crizotinib API Revenue by Manufacturer (2021-2026)
  • 3.3 Global Crizotinib API Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Crizotinib API by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Crizotinib API Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Crizotinib API Manufacturer Market Share in 2025
  • 3.5 Crizotinib API Market: Overall Company Footprint Analysis
    • 3.5.1 Crizotinib API Market: Region Footprint
    • 3.5.2 Crizotinib API Market: Company Product Type Footprint
    • 3.5.3 Crizotinib API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Crizotinib API Market Size by Region
    • 4.1.1 Global Crizotinib API Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Crizotinib API Consumption Value by Region (2021-2032)
    • 4.1.3 Global Crizotinib API Average Price by Region (2021-2032)
  • 4.2 North America Crizotinib API Consumption Value (2021-2032)
  • 4.3 Europe Crizotinib API Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Crizotinib API Consumption Value (2021-2032)
  • 4.5 South America Crizotinib API Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Crizotinib API Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Crizotinib API Sales Quantity by Type (2021-2032)
  • 5.2 Global Crizotinib API Consumption Value by Type (2021-2032)
  • 5.3 Global Crizotinib API Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Crizotinib API Sales Quantity by Application (2021-2032)
  • 6.2 Global Crizotinib API Consumption Value by Application (2021-2032)
  • 6.3 Global Crizotinib API Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Crizotinib API Sales Quantity by Type (2021-2032)
  • 7.2 North America Crizotinib API Sales Quantity by Application (2021-2032)
  • 7.3 North America Crizotinib API Market Size by Country
    • 7.3.1 North America Crizotinib API Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Crizotinib API Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Crizotinib API Sales Quantity by Type (2021-2032)
  • 8.2 Europe Crizotinib API Sales Quantity by Application (2021-2032)
  • 8.3 Europe Crizotinib API Market Size by Country
    • 8.3.1 Europe Crizotinib API Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Crizotinib API Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Crizotinib API Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Crizotinib API Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Crizotinib API Market Size by Region
    • 9.3.1 Asia-Pacific Crizotinib API Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Crizotinib API Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Crizotinib API Sales Quantity by Type (2021-2032)
  • 10.2 South America Crizotinib API Sales Quantity by Application (2021-2032)
  • 10.3 South America Crizotinib API Market Size by Country
    • 10.3.1 South America Crizotinib API Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Crizotinib API Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Crizotinib API Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Crizotinib API Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Crizotinib API Market Size by Country
    • 11.3.1 Middle East & Africa Crizotinib API Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Crizotinib API Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Crizotinib API Market Drivers
  • 12.2 Crizotinib API Market Restraints
  • 12.3 Crizotinib API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Crizotinib API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Crizotinib API
  • 13.3 Crizotinib API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Crizotinib API Typical Distributors
  • 14.3 Crizotinib API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Crizotinib API market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Crizotinib is an active pharmaceutical ingredient (API) used as a targeted therapy for cancers with ALK gene alterations,primarily non-small cell lung cancer (NSCLC).It works by inhibiting the ALK protein, which is involved in tumor growth.
    This report is a detailed and comprehensive analysis for global Crizotinib API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Crizotinib API market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
    Global Crizotinib API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
    Global Crizotinib API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
    Global Crizotinib API market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Crizotinib API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Crizotinib API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MSN Laboratories, Greencross, Hetero Labs, Vama Lifecare, Croissance Biomed, Medicine House, Apothecon Pharmaceuticals, Tocris Bioscience, Selleck Chemicals, Cayman Chemical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Crizotinib API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Purity≥99%
    Purity<99%
    Market segment by Application
    Online Sales
    Offline Sales
    Major players covered
    MSN Laboratories
    Greencross
    Hetero Labs
    Vama Lifecare
    Croissance Biomed
    Medicine House
    Apothecon Pharmaceuticals
    Tocris Bioscience
    Selleck Chemicals
    Cayman Chemical
    Anant Pharmaceuticals
    Adooq Bioscience
    Focus Biomolecules
    LC Laboratories
    Hefei Home Sunshine Pharmaceutical Technology
    Chongqing Huapont Shengchem Pharm
    Xuzhou Wanbang Jinqiao Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Crizotinib API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Crizotinib API, with price, sales quantity, revenue, and global market share of Crizotinib API from 2021 to 2026.
    Chapter 3, the Crizotinib API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Crizotinib API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Crizotinib API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Crizotinib API.
    Chapter 14 and 15, to describe Crizotinib API sales channel, distributors, customers, research findings and conclusion.

    Buy now